Analyst Consensus ?
ConsensusBuy36 ratings
Bullish2158.3%
Neutral1438.9%
Bearish12.8%
1 unmapped firm rating excluded from the percentages.
FN2 Earnings Intelligence
The Sherwin-Williams Company analyst ratings
The Sherwin-Williams Company (SHW) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$329.36Current
$260Low
$367.3Average
$420High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Outperform | Outperform | Maintain | Oct 9, 2026 |
| UBS | Neutral | Neutral | Maintain | Oct 5, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Sep 25, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jul 29, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 29, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Jul 29, 2026 |
| Citigroup | Buy | Buy | Maintain | Jun 24, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | May 8, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Apr 21, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Mar 23, 2026 |
| Loop Capital | Buy | Buy | Maintain | Jul 23, 2025 |
| Barclays | Equal Weight | Equal Weight | Maintain | Apr 1, 2025 |
| Jefferies | Hold | Buy | Downgrade | Mar 10, 2025 |
| Baird | Neutral | Neutral | Maintain | Oct 23, 2024 |
| Keybanc | Overweight | Downgrade | Oct 7, 2024 | |
| Goldman Sachs | Buy | Buy | Maintain | Jul 24, 2024 |
| Seaport Global | Neutral | Buy | Downgrade | Jan 8, 2024 |
| Northcoast Research | Neutral | Buy | Downgrade | Jan 2, 2024 |
| Argus Research | Buy | Buy | Maintain | Dec 21, 2023 |
| Berenberg | Hold | Hold | Maintain | Sep 29, 2023 |
| Deutsche Bank | Buy | Buy | Maintain | Jul 18, 2023 |
| Credit Suisse | Underperform | Underperform | Maintain | Jul 28, 2022 |
| Susquehanna | Neutral | Positive | Downgrade | Feb 5, 2020 |
| CFRA | Hold | Buy | Downgrade | Jan 30, 2020 |
| Edward Jones | Hold | Buy | Downgrade | Nov 20, 2019 |
| Buckingham Research | Neutral | Neutral | Maintain | Oct 23, 2019 |
| Buckingham | Neutral | Neutral | Maintain | Oct 23, 2019 |
| Bank of America | Buy | Buy | Maintain | Jul 25, 2018 |
| Argus | Buy | Hold | Upgrade | May 5, 2018 |
| Zelman | Buy | Hold | Upgrade | Oct 18, 2017 |
| Longbow Research | Buy | Neutral | Upgrade | Jun 13, 2017 |
| CLSA | Buy | Outperform | Maintain | Jul 22, 2016 |
| Sterne Agee CRT | Buy | Neutral | Upgrade | Aug 25, 2015 |
| Sterne Agee | Buy | Neutral | Upgrade | Aug 25, 2015 |
| Wolfe Research | Outperform | Peer Perform | Upgrade | Apr 23, 2015 |
| Nomura | Buy | Neutral | Upgrade | Apr 15, 2013 |
| Credit Agricole | Outperform | Underperform | Upgrade | Nov 13, 2012 |
Named analyst price targets
Upside is calculated against the persisted current price $329.36. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Analyst unavailable | $348 | $320.21 | +5.7% | Oct 12, 2026 |
| RBC Capital | Arun Viswanathan | $392 | $318.54 | +19.0% | Oct 9, 2026 |
| Melius Research | Michael Rehaut | $367 | $318.46 | +11.4% | Oct 6, 2026 |
| UBS | Analyst unavailable | $363 | $319.51 | +10.2% | Oct 5, 2026 |
| Wells Fargo | Analyst unavailable | $340 | $320.4 | +3.2% | Sep 25, 2026 |
| Mizuho Securities | John Roberts | $396 | $326.46 | +20.2% | Sep 24, 2026 |
| D.A. Davidson | Analyst unavailable | $400 | $346.73 | +21.4% | Aug 24, 2026 |
| Guggenheim | Analyst unavailable | $400 | $340.85 | +21.4% | Aug 3, 2026 |
| Goldman Sachs | Duffy Fischer | $420 | $343.88 | +27.5% | Jul 29, 2026 |
| BMO Capital | Analyst unavailable | $405 | $341.42 | +23.0% | Jul 29, 2026 |
| UBS | Joshua Spector | $390 | $341.57 | +18.4% | Jul 29, 2026 |
| Wells Fargo | Analyst unavailable | $360 | $354.27 | +9.3% | Jul 29, 2026 |
| Morgan Stanley | Vicent Andrews | $395 | $354.27 | +19.9% | Jul 29, 2026 |
| Jefferies | Laurence Alexander | $375 | $354.27 | +13.9% | Jul 28, 2026 |
| Berenberg Bank | Aron Ceccarelli | $380 | $305.3 | +15.4% | Jun 8, 2026 |
| BMO Capital | Analyst unavailable | $355 | $297.49 | +7.8% | Jun 3, 2026 |
| UBS | Analyst unavailable | $330 | $294.86 | +0.2% | Jun 2, 2026 |
| Evercore ISI | Analyst unavailable | $390 | $317.6 | +18.4% | Apr 29, 2026 |
| Wells Fargo | Analyst unavailable | $365 | $335.59 | +10.8% | Apr 10, 2026 |
| Mizuho Securities | Analyst unavailable | $410 | $368.89 | +24.5% | Feb 17, 2026 |
| UBS | Analyst unavailable | $420 | $355.36 | +27.5% | Jan 30, 2026 |
| RBC Capital | Analyst unavailable | $390 | $354.58 | +18.4% | Jan 30, 2026 |
| Deutsche Bank | Analyst unavailable | $380 | $350.63 | +15.4% | Jan 22, 2026 |
| UBS | Joshua Spector | $415 | $356.34 | +26.0% | Jan 12, 2026 |
| Vertical Research | Analyst unavailable | $371 | $340.09 | +12.6% | Jan 7, 2026 |
| Mizuho Securities | Analyst unavailable | $390 | $327.95 | +18.4% | Dec 18, 2025 |
| Mizuho Securities | Analyst unavailable | $400 | $351.2 | +21.4% | Oct 29, 2025 |
| RBC Capital | Analyst unavailable | $405 | $354.45 | +23.0% | Oct 29, 2025 |
| UBS | Analyst unavailable | $422 | $351.2 | +28.1% | Oct 29, 2025 |
| Wells Fargo | Michael Sison | $410 | $354.45 | +24.5% | Oct 29, 2025 |
| Wells Fargo | Analyst unavailable | $395 | $333.22 | +19.9% | Oct 10, 2025 |
| UBS | Analyst unavailable | $400 | $338.31 | +21.4% | Oct 6, 2025 |
| Mizuho Securities | John Roberts | $395 | $336.77 | +19.9% | Apr 15, 2025 |
| Jefferies | Laurence Alexander | $380 | $363.62 | +15.4% | Mar 10, 2025 |
| Robert W. Baird | Ghansham Panjabi | $370 | $358.16 | +12.3% | Jan 31, 2025 |
| RBC Capital | Arun Viswanathan | $438 | $334.4 | +33.0% | Jan 14, 2025 |
| Mizuho Securities | John Roberts | $408 | $334.4 | +23.9% | Jan 7, 2025 |
| Jefferies | Laurence Alexander | $423 | $345.47 | +28.4% | Jan 2, 2025 |
| RBC Capital | Arun Viswanathan | $446 | $362.72 | +35.4% | Oct 24, 2024 |
| Robert W. Baird | Ghansham Panjabi | $360 | $361.38 | +9.3% | Oct 23, 2024 |
| Goldman Sachs | Duffy Fischer | $410 | $361.38 | +24.5% | Oct 23, 2024 |
| Evercore ISI | Greg Melich | $400 | $361.38 | +21.4% | Oct 23, 2024 |
| Barclays | Michael Leithead | $370 | $361.38 | +12.3% | Oct 23, 2024 |
| Jefferies | Laurence Alexander | $445 | $388.36 | +35.1% | Oct 21, 2024 |
| BMO Capital | John McNulty | $400 | $363.75 | +21.4% | Sep 3, 2024 |
| Jefferies | Laurence Alexander | $415 | $358.73 | +26.0% | Aug 26, 2024 |
| Berenberg Bank | Aron Ceccarelli | $312 | $352.55 | -5.3% | Jul 30, 2024 |
| Deutsche Bank | David Begleiter | $385 | $340 | +16.9% | Jul 24, 2024 |
| Robert W. Baird | Ghansham Panjabi | $325 | $344.5 | -1.3% | Jul 24, 2024 |
| Barclays | Michael Leithead | $355 | $344.5 | +7.8% | Jul 24, 2024 |
| UBS | Joshua Spector | $355 | $298.95 | +7.8% | Jul 9, 2024 |
| BMO Capital | John McNulty | $360 | $296 | +9.3% | Jun 11, 2024 |
| Jefferies | Laurence Alexander | $370 | $301.73 | +12.3% | May 29, 2024 |
| RBC Capital | Arun Viswanathan | $370 | $303.73 | +12.3% | Apr 25, 2024 |
| KeyBanc | Kenneth Zener | $400 | $303.73 | +21.4% | Apr 25, 2024 |
| Morgan Stanley | Vicent Andrews | $338 | $302.03 | +2.6% | Apr 23, 2024 |
| Mizuho Securities | John Roberts | $334 | $296.76 | +1.4% | Apr 23, 2024 |
| Goldman Sachs | Duffy Fischer | $348 | $296.76 | +5.7% | Apr 23, 2024 |
| BMO Capital | John McNulty | $385 | $296.76 | +16.9% | Apr 23, 2024 |
| Deutsche Bank | David Begleiter | $350 | $296.76 | +6.3% | Apr 23, 2024 |
| Evercore ISI | Greg Melich | $350 | $309.38 | +6.3% | Apr 19, 2024 |
| UBS | Analyst unavailable | $255 | $241.82 | -22.6% | Jan 11, 2023 |
| Wells Fargo | Analyst unavailable | $220 | $240.04 | -33.2% | Jan 9, 2023 |
| J.P. Morgan | Analyst unavailable | $260 | $251.24 | -21.1% | Dec 2, 2022 |
| Mizuho Securities | Analyst unavailable | $294 | $245.72 | -10.7% | Jul 14, 2022 |
| Barclays | Michael Leithead | $303 | $272.32 | -8.0% | May 2, 2022 |
| RBC Capital | Analyst unavailable | $342 | $277.21 | +3.8% | Apr 28, 2022 |
| Wells Fargo | Analyst unavailable | $285 | $279.52 | -13.5% | Apr 27, 2022 |
| Wells Fargo | Truman Patterson | $275 | $244.92 | -16.5% | Apr 24, 2022 |
| Loop Capital Markets | Garik Shmois | $300 | $261.1 | -8.9% | Apr 11, 2022 |
| Jefferies | Laurence Alexander | $275 | $244.38 | -16.5% | Mar 16, 2022 |
| Robert W. Baird | Ghansham Panjabi | $350 | $287.03 | +6.3% | Jan 28, 2022 |
| Mizuho Securities | Chris Parkinson | $350 | $287.03 | +6.3% | Jan 28, 2022 |
| BMO Capital | John McNulty | $310 | $287.03 | -5.9% | Jan 28, 2022 |
| Barclays | Duffy Fischer | $345 | $292.85 | +4.7% | Jan 22, 2022 |
| Wells Fargo | Michael Sison | $335 | $305.51 | +1.7% | Jan 18, 2022 |
| Citigroup | PJ Juvekar | $358 | $323.75 | +8.7% | Jan 11, 2022 |
| Morgan Stanley | Vincent Andrews | $375 | $323.75 | +13.9% | Jan 11, 2022 |
| Goldman Sachs | Robert Koort | $320 | $344.84 | -2.8% | Dec 15, 2021 |
| Berenberg Bank | Anthony Manning | $310 | $316.12 | -5.9% | Oct 27, 2021 |
| Wolfe Research | Truman Patterson | $325 | $285.88 | -1.3% | Jul 28, 2021 |
| Argus Research | Bill Selesky | $325 | $281.31 | -1.3% | May 4, 2021 |
Track every rating change on SHW the moment it posts. Free to start.
Start freeGet the SHW recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.